Growth Metrics

Carlsmed (CARL) Operating Leases (2024 - 2026)

Carlsmed posted quarterly Operating Leases of $1.1 million for Q1 2026, down 15.27% on a QoQ basis from $1.3 million in Q4 2025.

Carlsmed (CARL) has 3 years of Operating Leases data on file, last reported at $1.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (changed N/A YoY), and the FY2025 full-year result was $1.3 million, changed 0.08% from the prior year.
  • Operating Leases for Q1 2026 stood at $1.1 million, down from $1.3 million in the prior quarter.
  • Across five years, Operating Leases topped out at $1.7 million in Q2 2025 and bottomed at $1.1 million in Q1 2026.
  • The 3-year median for Operating Leases is $1.3 million (2024), against an average of $1.4 million.
  • Peak annual rise in Operating Leases reached 0.08% in 2025, while the deepest fall reached 0.08% in 2025.
  • A 3-year view of Operating Leases shows it stood at $1.3 million in 2024, then slipped by 0.08% to $1.3 million in 2025, then dropped by 15.27% to $1.1 million in 2026.
  • The last three Operating Leases figures came in at $1.1 million (Q1 2026), $1.3 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 Carlsmed 298.68 Mn 201.48 Mn 12.43 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.12 Mn
Dec 31, 2025 1.32 Mn
Sep 30, 2025 1.51 Mn
Jun 30, 2025 1.71 Mn
Dec 31, 2024 1.32 Mn